Has Michael Boxer received payments from drug or device companies?

Yes. Drug and device makers reported $120,706 in general payments to Michael Boxer across 274 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Boxer did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Boxer come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Boxer

Hematology & Oncology · Tucson, AZNPI 1275502544

Payments from drug & device makers

$120,706in general payments, 2019–2025

Across 274 payments — averaging $440.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bioverativ Therapeutics Inc.$37K
Genentech, Inc.$26K
Rigel Pharmaceuticals, Inc.$23K
Takeda Pharmaceuticals U.S.A., Inc.$9K
AbbVie$6K
Acerta Pharma LLC$5K
plus $15K from 40 others

$6,241in research payments, 2019–2025

Across 4 payments — averaging $1560.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

F. Hoffmann-la Roche AG$5K
Acerta Pharma LLC$1K

What the payments were for

Consulting fees$5,87520%
Speaking & faculty fees$18,63562%
Travel & lodging$1,4885%
Food & beverage$3,80913%
Education$2281%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bioverativ Therapeutics Inc.	6	$36,897
Genentech, Inc.	10	$25,578
Rigel Pharmaceuticals, Inc.	9	$23,197
Takeda Pharmaceuticals U.S.A., Inc.	12	$9,252
AbbVie	5	$5,849
Acerta Pharma LLC	2	$5,000
Sanofi	9	$3,094
Adaptive Biotechnologies Corporation	2	$2,095
F. Hoffmann-la Roche AG	4	$2,052
Karyopharm Therapeutics Inc.	3	$1,585
Beigene USA, Inc.	1	$1,350
Beigene, Ltd.	2	$975
Pharmacosmos Therapeutics Inc.	2	$667
Amgen	27	$327
Genentech USA, Inc.	17	$278
E.r. Squibb & Sons, L.L.C.	20	$262
Pfizer	29	$224
Johnson & Johnson	10	$218
Bayer	17	$203
AstraZeneca(2 entities)	12	$190
Merck	17	$176
Aurobindo Pharma USA, Inc.	4	$162
Agios Pharmaceuticals, Inc.	1	$140
Novartis	9	$129
Astellas Pharma US Inc	3	$124
Pharmacyclics LLC, An Abbvie Company	7	$122
Lilly USA, LLC	4	$53
Sun Pharmaceutical Industries Inc.	2	$47
Boehringer Ingelheim	3	$42
Bristol Myers Squibb	2	$41
Puma Biotechnology, Inc.	2	$38
Gilead	3	$37
Incyte Corporation	2	$37
Exelixis Inc.	2	$34
Dova Pharmaceuticals	2	$30
Cardinal Health 414 LLC	1	$29
Seagen Inc.	2	$26
Shire North American Group Inc	1	$24
Sanofi-aventis U.S. LLC	1	$21
Regeneron Healthcare Solutions, Inc.	1	$18
Advanced Accelerator Applications	1	$18
AMAG Pharmaceuticals, Inc.	1	$16
Blueprint Medicines Corporation	1	$15
Ipsen Biopharmaceuticals, Inc	1	$13
Secura Bio, Inc.	1	$13
Clovis Oncology, Inc.	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NINLARO$8,964
Venclexta$5,749
CEREZYME$2,877
CERDELGA$2,877
BRUKINSA$2,325
GAZYVA$2,052
clonoSEQ$2,000
XPOVIO$1,550
Monoferric$656
TIBSOVO$140
Beleodaq$134
Folotyn$134

How this compares

$120,706 in reported general payments places this provider in the 65th percentile of 261 hematology & oncology providers in Arizona.

See all hematology & oncology providers in Arizona →

Other hematology & oncology in Tucson

Sudhir MandaTucson$10M
Rachna ShroffTucson$3M
Aaron ScottTucson$2.6M
Manuel Modiano RevahTucson$1.7M
Rachel SwartTucson$1.6M
Aisha AhmedTucson$1.6M
Faiz AnwerTucson$1.3M
Alison StopeckTucson$1.3M
Ahmed AbdelazizTucson$962K
Ricklie JulianTucson$840K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →